Synova WAVE System
Processing of adipose tissue for autologous transplantation
Key Facts
About Synova Life Sciences
Synova Life Sciences is a private, pre-revenue medical device company that has developed the FDA 510(k)-cleared Synova WAVE system for rapid, high-viability adipocyte (fat cell) processing. The technology differentiates itself through a 3-minute processing time and superior cell viability (over 90%) compared to competitors, targeting the growing market for fat grafting and cell-based therapies in oncology and reconstructive surgery. Led by a founder-inventor CEO and an experienced operational and commercial team, the company is positioned to commercialize its platform for clinical use, though it faces risks related to market adoption, reimbursement, and competition from established players.
View full company profile